Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | MAPT | P10636 | 4/20 | 0.68 |
| ▸ | POLB | P06746 | 2/20 | 0.68 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | F2 | P00734 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.48 |
| ▸ | PKM | P14618 | 3/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | F10 | P00742 | 1/20 | 0.48 |
| ▸ | F12 | P00748 | 1/20 | 0.48 |
| ▸ | F7 | P08709 | 1/20 | 0.48 |
| ▸ | F3 | P13726 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27483793 | 0.98 | KMT2A (0.66) | KMT2AALDH1A1MAPTPOLBTSHR | |
| SCHEMBL7555577 | 0.89 | ALDH1A1 (0.52) | KMT2AALDH1A1MAPTPOLBTSHR | |
| SCHEMBL8641757 | 0.86 | ALDH1A1 (0.50) | KMT2AALDH1A1MAPTPOLBF2 | |
| SCHEMBL6269137 | 0.85 | ALDH1A1 (0.70) | KMT2AALDH1A1MAPTPOLBTSHR | |
| SCHEMBL9699705 | 0.85 | ALDH1A1 (0.59) | KMT2AALDH1A1MAPTPOLBTSHR | |
| SCHEMBL4907232 | 0.85 | ALDH1A1 (0.76) | KMT2AALDH1A1MAPTPOLBTSHR | |
| Hydrochloric Acid SCHEMBL29271905 | 0.83 | ALDH1A1 (0.58) | KMT2AALDH1A1MAPTPOLBTSHR | |
| SCHEMBL9150262 | 0.82 | ALDH1A1 (0.66) | KMT2AALDH1A1MAPTPOLBTSHR | |
| SCHEMBL12348301 | 0.82 | KMT2A (0.66) | KMT2AALDH1A1MAPTPOLBTSHR | |
| SCHEMBL184146 | 0.81 | ALDH1A1 (0.44) | KMT2AALDH1A1MAPTPOLBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12398222-B2 | Flame-retardant antimicrobial agent, preparation method therefor and use thereof, and flame-retardant antimicrobial thermoplastic resin composition | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2025-08-26 | — | — | US | claimed |
| EP-4053177-B1 | FLAME-RETARDANT ANTIMICROBIAL AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF, AND FLAME-RETARDANT ANTIMICROBIAL THERMOPLASTIC RESIN COMPOSITION | CHINA PETROLEUM & CHEM CORP (CN) | 2025-01-22 | — | — | EP | claimed |
| CN-118724761-A | Preparation method of novel guanidine benzoate derivatives and application of guanidine benzoate derivatives in pancreatitis | 天津理工大学 | 2024-10-01 | — | — | CN | claimed |
| CN-115260646-B | Flame-retardant antibacterial thermoplastic resin composition and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-115260506-B | Flame-retardant antibacterial agent and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-115230271-B | High-barrier anti-adhesion composite film and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-114427124-B | Antibacterial flame-retardant polypropylene fiber composition, preparation method thereof, fiber and non-woven fabric | 中国石油化工股份有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-114341211-B | Flame-retardant antibacterial agent, preparation method and application thereof, and flame-retardant antibacterial thermoplastic resin composition | 中国石油化工股份有限公司 | 2023-11-21 | — | — | CN | claimed |
| CN-117004199-A | Antibacterial glass fiber reinforced polyglycolic acid composite material and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-114474923-B | Polyethylene rotational molding body and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-10-10 | — | — | CN | claimed |
| WO-2009002913-A1 | USE OF CREATINE COMPOUNDS TO TREAT DERMATITIS | AVICENA GROUP, INC. (US) | 2008-12-31 | — | — | WO | claimed |
| EP-1198230-A4 | USE OF CREATINE OR CREATINE COMPOUNDS FOR SKIN PRESERVATION | ENERDERMICS INC (US) | 2004-06-16 | — | — | EP | claimed |
| US-20040054006-A1 | Use of creatine or creatine analogs for the prevention and treatment of Transmissible Spongiform Encephalopathies | KADDURAH-DAOUK RIMA (US) | 2004-03-18 | — | — | US | claimed |
| US-20020049253-A1 | Use of creatine or creatine compounds for skin preservation | AVICENA GROUP, INC. | 2002-04-25 | — | — | US | claimed |
| EP-1198230-A1 | USE OF CREATINE OR CREATINE COMPOUNDS FOR SKIN PRESERVATION | Avicena Group, Inc. (US) | 2002-04-24 | — | — | EP | claimed |
| US-6242491-B1 | ADMINISTERING CREATINE PHOSPHATE FOR WRINKLE, AGING, AND SOLAR RADIATION RESISTANCE AND AS FREE RADICAL SCAVENGER | LIBRARY PHARMA, INC. | 2001-06-05 | — | — | US | claimed |
| WO-2001000212-A1 | USE OF CREATINE OR CREATINE ANALOGS FOR THE PREVENTION AND TREATMENT OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES | AVICENA GROUP, INC. (US) | 2001-01-04 | — | — | WO | claimed |
| WO-2001000203-A1 | USE OF CREATINE OR CREATINE COMPOUNDS FOR SKIN PRESERVATION | AVICENA GROUP, INC. (US) | 2001-01-04 | — | — | WO | claimed |
| US-4703014-A | Karl-Fischer reagent and process for the determination of water | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1987-10-27 | — | — | US | claimed |
| EP-0229370-A1 | Guanidinobenzoic ester derivative, a process for preparing same and pharmaceutical compositions containing same | Eisai Co., Ltd. (JP) | 1987-07-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049253-A1 | Use of creatine or creatine compounds for skin preservation | PC, CKMT1A; CKMT1B, CHEK1 | KMT2A 2210/4885ALDH1A1 2904/4885MAPT 3406/4885 |
| US-20040054006-A1 | Use of creatine or creatine analogs for the prevention and treatment of Transmissible Spongiform Encephalopathies | PRNP, CKMT1A; CKMT1B, PRPS1 | KMT2A 2152/4885ALDH1A1 3272/4885MAPT 861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.